Nuvation Bio (NUVB) Change in Accured Expenses (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Change in Accured Expenses of -$12.3 million for Q1 2026, down 37.78% year-over-year from -$19.8 million in Q1 2025, and down 197.74% quarter-over-quarter from $12.6 million in Q4 2025.
Nuvation Bio (NUVB) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Change in Accured Expenses for 7 consecutive years, with -$12.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 37.78% year-over-year to -$12.3 million; the TTM figure through Mar 2026 stood at $9.0 million (up 348.33% YoY), while the FY2025 annual figure was $12.4 million, up 80.61% from the prior year.
- Change in Accured Expenses eased to -$12.3 million in Q1 2026 per NUVB's latest filing, from $12.6 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $12.6 million in Q4 2025 and bottomed at -$12.3 million in Q1 2026.
- Historically, Change in Accured Expenses has averaged $266176.5 across 5 years, with a median of $483000.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses sank 1962.0% — and 2024, when it jumped 455.38%.
- Nuvation Bio's Change in Accured Expenses stood at -$100000.0 in 2022, then tumbled by 1962.0% to -$2.1 million in 2023, then surged by 455.38% to $7.3 million in 2024, then surged by 72.0% to $12.6 million in 2025, then plunged by 197.74% to -$12.3 million in 2026.
- Business Quant data shows NUVB's Change in Accured Expenses at -$12.3 million in Q1 2026, $12.6 million in Q4 2025, and $8.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 55.78 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 212.44 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 61.62 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 13.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.77 Mn |
| Jun 30, 2026 | 13.77 Mn |
| Mar 31, 2026 | -12.32 Mn |
| Mar 31, 2026 | -12.32 Mn |
| Dec 31, 2025 | 12.60 Mn |
| Dec 31, 2025 | 12.60 Mn |
| Sep 30, 2025 | 8.58 Mn |
| Sep 30, 2025 | 8.58 Mn |
| Jun 30, 2025 | 106,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | -8.94 Mn |
| Mar 31, 2025 | -8.94 Mn |
| Dec 31, 2024 | 7.33 Mn |
| Dec 31, 2024 | 7.33 Mn |
| Sep 30, 2024 | 3.53 Mn |
| Sep 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | -5.53 Mn |
| Jun 30, 2024 | -5.53 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |